L3VLUP

AKTS in the 13F filings

Aktis Oncology Inc · CUSIP 01021M104

New listing in Q1 2026· first held by a tracked manager this quarter, so its new positions are allocations rather than a turn towards it

Quarter end
31 Mar 2026
the date the book describes
Filed
18 May 2026
latest of these filings; the earliest 12 May 2026
Managers listing it
9
at least, of 95 tracked, among listed positions
Comparable managers
91
filed both Q4 2025 and Q1 2026; 0 listed it in both
Shares listed
6,026,061
combined, among listed positions
Reported value
$108m
combined, at the quarter end

Among the 91 comparable managers: 9 buyers (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +6,026,061.

Managers listing AKTS in Q1 2026

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

9 of 9 holders

Largest increases and reductions, by shares

There is no earlier quarter on file to compare with.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q1 2026 to 3 in Q2 2026

Tracked managers listing it, at least.

0123Q1 2026Q2 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
AKTS by quarter
QuarterHoldersReported valueBuyersSellers
Q1 20261$1.8m90
Q2 20263$48m96

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

AKTS and LLY →AKTS and JNJ →AKTS and VRTX →Choose a stock to compare with AKTS →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own AKTS, latest filings →Back to the 13F Explorer →